We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
S Mustafa

S Shahzad Mustafa MD

Chief of Allergy, Immunology, Rheumatology at Rochester Regional Health; Clinical Associate Professor of Medicine at the University of Rochester School of Medicine and Dentistry, Rochester, New York

Dr. Mustafa pursued his undergraduate studies at the Johns Hopkins University and attended medical school at SUNY Buffalo. He then completed his internal medicine training at the University of Colorado and stayed in Denver to complete his fellowship training in allergy and clinical immunology at the University of Colorado, National Jewish Health, and Children’s Hospital of Denver. Dr. Mustafa is the division chief for allergy, immunology, and rheumatology at Rochester Regional Health, where he sees both pediatric and adult patients. Dr. Mustafa is also on faculty at the University of Rochester, where he is Clinical Associate Professor of Medicine, and the clerkship director for the medical student elective in allergy/clinical immunology. In addition to teaching and seeing patients, Dr. Mustafa is also a lead investigator on multiple clinical research projects, with a special interest in quality of life considerations in the management of food allergy and secondary immunodeficiency.

Disclosures

Although Dr. Mustafa is on the speaker’s bureau for Genentech, AstraZeneca, Regeneron, and CSL Behring and receives grant monies from CSL Behring, he declares no relevant financial disclosures related to this article.